These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26056901)

  • 21. Calcineurin inhibitors: a novel approach to canine atopic dermatitis.
    Marsella R
    J Am Anim Hosp Assoc; 2005; 41(2):92-7. PubMed ID: 15767651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atopic keratoconjunctivitis and atopic dermatitis.
    Guglielmetti S; Dart JK; Calder V
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):478-85. PubMed ID: 20720488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review.
    Blake SC; Murrell DF
    Pediatr Dermatol; 2019 Nov; 36(6):843-853. PubMed ID: 31566785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A DESCRIPTION OF ARTERIAL BLOOD PRESSURE MEASUREMENT IN TWO SPECIES OF FLYING FOXES (
    Gatson BJ; Paranjape V; Wellehan JFX; Bailey K
    J Zoo Wildl Med; 2019 Sep; 50(3):665-671. PubMed ID: 33517637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine in veterinary dermatology.
    Palmeiro BS
    Vet Clin North Am Small Anim Pract; 2013 Jan; 43(1):153-71. PubMed ID: 23182330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cyclosporin A in atopic dermatitis: therapeutic effect and effect on allergic reactions are dissociated from each other].
    Munro CS; Higgins EM; Marks JM; Daly BM; Friedmann PS; Shuster S
    Wien Med Wochenschr; 1991; 141(18-19):419-23. PubMed ID: 1776256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
    Law Ping Man S; Bouzillé G; Beneton N; Safa G; Dupuy A; Droitcourt C
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1327-1335. PubMed ID: 29444359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Treatment for Severe Atopic Dermatitis.
    Giavina-Bianchi M; Giavina-Bianchi P
    Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):69-78. PubMed ID: 30159581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsiveness and validity of the SCORFAD, an extent and severity scale for feline hypersensitivity dermatitis.
    Steffan J; Olivry T; Forster SL; Seewald W
    Vet Dermatol; 2012 Oct; 23(5):410-e77. PubMed ID: 22823903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of body weight to maintenance cyclosporine a dose in canine atopic dermatitis.
    Cohen L; Zabel S; Rosychuk RA
    J Am Anim Hosp Assoc; 2014; 50(3):174-80. PubMed ID: 24659725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dupilumab-Induced Follicular Conjunctivitis.
    Shen E; Xie K; Jwo K; Smith J; Mosaed S
    Ocul Immunol Inflamm; 2019; 27(8):1339-1341. PubMed ID: 30335586
    [No Abstract]   [Full Text] [Related]  

  • 32. Omalizumab for the treatment of atopic dermatitis.
    Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
    Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of non-specific anti-pruritus treatment with cyclosporine A on transepidermal water loss (TEWL) in natural atopic dermatitis in dogs.
    Zając M; Szczepanik M; Wilkołek P; Adamek Ł; Pomorski Z
    Pol J Vet Sci; 2015; 18(2):415-24. PubMed ID: 26172193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is new in atopic dermatitis/eczema?
    Plötz SG; Wiesender M; Todorova A; Ring J
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):441-58. PubMed ID: 25286776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
    Kim CH; Choi YS; Cheong KA; Lee AY
    Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice.
    Daguzé J; Aubert H; Bernier C; Gaultier A; Nguyen JM; Stalder JF; Barbarot S
    Acta Derm Venereol; 2017 Aug; 97(8):955-956. PubMed ID: 28448098
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
    Steffan J; Strehlau G; Maurer M; Rohlfs A
    J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate Hypersensitivity Reactions Induced by Triamcinolone in a Patient with Atopic Dermatitis.
    Son JH; Park SY; Cho YS; Chung BY; Kim HO; Park CW
    J Korean Med Sci; 2018 Mar; 33(12):e87. PubMed ID: 29542298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.